Picture of Cullinan Therapeutics logo

CGEM — Cullinan Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Cullinan Oncology Q3 Adjusted Net Income USD -39.2 Million

Nov 08 (Reuters) - Cullinan Oncology Q3 cash & investments USD 482 million

Recent news on Cullinan Therapeutics

See all news